Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Important drug-drug interactions in the elderly

R M Seymour1, P A Routledge

  • 1Department of Pharmacology, Therapeutics and Toxicology, University of Wales College of Medicine, Cardiff.

Drugs & Aging
|June 25, 1998
PubMed
Summary

Drug-drug interactions are predictable and manageable, especially in the elderly. Limiting prescriptions, regular reviews, and patient-pharmacist partnerships can reduce adverse drug events and improve patient safety.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A change in the trend in dosulepin usage following the introduction of a prescribing indicator but not after two national safety warnings.

Journal of clinical pharmacy and therapeutics·2016
Same author

A comparative study of methyldopa and labetalol in the treatment of hypertension.

British journal of clinical pharmacology·2015
Same author

Mean steady-state plasma concentrations of labetalol in patients undergoing antihypertensive therapy.

British journal of clinical pharmacology·2015
Same author

A multicentre open trial of labetalol in New Zealand.

British journal of clinical pharmacology·2015
Same author

Impact of anti-cancer drugs and other determinants on serum protein binding of morphine 6-glucuronide.

Daru : journal of Faculty of Pharmacy, Tehran University of Medical Sciences·2012
Same author

Mate choice among yeast gametes can purge deleterious mutations.

Journal of evolutionary biology·2012

Area of Science:

  • Geriatrics
  • Clinical Pharmacology
  • Patient Safety

Background:

  • Drug-drug interactions (DDIs) are a significant cause of adverse drug reactions, often predictable and preventable.
  • DDI frequency increases with patient age, polypharmacy, multiple prescribers, and frailty.
  • Key interaction mechanisms include altered drug metabolism and pharmacodynamic effects, leading to increased or decreased drug action.

Purpose of the Study:

  • To highlight the importance of drug-drug interactions in clinical practice.
  • To discuss the mechanisms and contributing factors of DDIs.
  • To outline strategies for preventing and managing DDIs, particularly in the elderly population.

Main Methods:

  • Review of literature on drug-drug interactions.
  • Analysis of factors influencing DDI frequency and severity.
  • Discussion of preventative and management strategies.

Main Results:

  • While severe consequences are rare, subclinical morbidity from DDIs is common in the elderly, presenting as nonspecific symptoms.
  • Approximately 10% of potential DDIs lead to clinically significant events.
  • Interactions causing loss of drug efficacy are as common as those causing increased effects.

Conclusions:

  • Limiting the number of prescribed drugs and regular medication reviews are crucial for minimizing DDIs.
  • Encouraging patient involvement in a 'prescribing partnership' enhances early detection of adverse events.
  • Multidisciplinary education on aging, drug handling, and DDI presentations is vital for prevention in the elderly.

Related Experiment Videos